Other Species / Isoforms
  VAMP2 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T35-p
SNRRLQQtQAQVDEV
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Putative in vivo kinases:
  • ATR (mouse)
VAMP2 (human) SNRRLQQTQAQVDEV T35
VAMP2 (mouse) SNRRLQQtQAQVDEV T35-p
VAMP2 (rat) SNRRLQQTQAQVDEV T35
K52-ub
IMRVNVDkVLERDQk
0 107
VAMP2 (human) IMRVNVDkVLERDQk K52-ub
VAMP2 (mouse) IMRVNVDkVLERDQk K52-ub
VAMP2 (rat) IMRVNVDkVLERDQk K52-ub
K59-ub
kVLERDQkLsELDDR
0 103
VAMP2 (human) kVLERDQkLsELDDR K59-ub
VAMP2 (mouse) kVLERDQkLsELDDR K59-ub
VAMP2 (rat) kVLERDQkLsELDDR K59-ub
S61-p
LERDQkLsELDDRAD
Upstream
1 36
Kinase, in vitro:
  • CAMK2A (rat)
Treatment
  • LPS
VAMP2 (human) LERDQkLsELDDRAD S61-p
VAMP2 (mouse) LERDQkLsELDDRAD S61-p
VAMP2 (rat) LERDQkLsELDDRAD S61-p
S75-p
DALQAGAsQFEtsAA
1 50
VAMP2 (human) DALQAGAsQFEtsAA S75-p
VAMP2 (mouse) DALQAGAsQFEtsAA S75-p
VAMP2 (rat) DALQAGAsQFETSAA S75-p
T79-p
AGAsQFEtsAAkLKR
0 2
VAMP2 (human) AGAsQFEtsAAkLkR T79-p
VAMP2 (mouse) AGAsQFEtsAAkLKR T79-p
VAMP2 (rat) AGAsQFETSAAKLkR T79
S80-p
GAsQFEtsAAkLKRK
0 13
VAMP2 (human) GAsQFEtsAAkLkRK S80-p
VAMP2 (mouse) GAsQFEtsAAkLKRK S80-p
VAMP2 (rat) GAsQFETSAAKLkRK S80
K83-ub
QFEtsAAkLKRKYWW
0 20
VAMP2 (human) QFEtsAAkLkRKYWW K83-ub
VAMP2 (mouse) QFEtsAAkLKRKYWW K83-ub
VAMP2 (rat) QFETSAAKLkRKYWW K83
K85
EtsAAkLKRKYWWKN
0 8
VAMP2 (human) EtsAAkLkRKYWWkN K85-ub
VAMP2 (mouse) EtsAAkLKRKYWWKN K85
VAMP2 (rat) ETSAAKLkRKYWWKN K85-ub
K91
LKRKYWWKNLKMMII
0 1
VAMP2 (human) LkRKYWWkNLKMMII K91-ub
VAMP2 (mouse) LKRKYWWKNLKMMII K91
VAMP2 (rat) LkRKYWWKNLKMMII K91